JASPER KAUFMAN: Open Payments
NPI 1134686538 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,122 in 112 payments from 24 companies in 2025. Trend: 2023 $2,288 · 2024 $1,715 · 2025 $2,122
Food & beverage: $2,122
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $295 |
| ViiV Healthcare Company | 9 | $279 |
| Lilly USA, LLC | 16 | $183 |
| AstraZeneca Pharmaceuticals LP | 8 | $175 |
| PFIZER INC. | 12 | $168 |
| Amgen Inc. | 5 | $157 |
| Lundbeck LLC | 7 | $114 |
| Otsuka America Pharmaceutical, Inc. | 5 | $111 |
| Novo Nordisk Inc | 5 | $104 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $95 |
Products named: APRETUDE, REXULTI, MOUNJARO, VRAYLAR, REPATHA, NURTEC ODT, CAPLYTA, TZIELD.
Industry payments across NE — which companies pay providers there.
